Your browser doesn't support javascript.
loading
Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy.
Culha, Mehmet Gokhan; Inkaya, Ahmet Cagkan; Yildirim, Emre; Unal, Serhat; Serefoglu, Ege Can.
Affiliation
  • Culha MG; Department of Urology, Istanbul Training & Research Hospital, Istanbul, Turkey.
  • Inkaya AC; Department of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey.
  • Yildirim E; Novo Nordisk Turkey, CMRQ Department, Istanbul, Turkey.
  • Unal S; Department of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey.
  • Serefoglu EC; Department of Urology, Bagcilar Training & Research Hospital, Istanbul, Turkey. Electronic address: egecanserefoglu@hotmail.com.
Med Hypotheses ; 94: 151-3, 2016 Sep.
Article in En | MEDLINE | ID: mdl-27515222
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Acquired Immunodeficiency Syndrome / Anti-Retroviral Agents / Glucagon-Like Peptide 1 / Hypoglycemic Agents Type of study: Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Med Hypotheses Year: 2016 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Acquired Immunodeficiency Syndrome / Anti-Retroviral Agents / Glucagon-Like Peptide 1 / Hypoglycemic Agents Type of study: Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Med Hypotheses Year: 2016 Document type: Article Affiliation country: